PRA Health Sciences Inc. (NASDAQ: PRAH)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of
PRA Health Sciences Inc. (NASDAQ: PRAH) in connection with the proposed acquisition of the company by ICON plc ("ICLR"). Under the terms of the merger agreement, PRAH shareholders will receive $80.00 in cash and 0.4125 shares of stock for each share of PRAH common stock that they own, representing implied per-share merger consideration of approximately $165.12 based upon ICLR's April 20, 2021 closing price of $206.36. If you own TPCO shares and wish to discuss this investigation or your rights, please call us or visit our website: https://weisslawllp.com/prah/